Tumors harboring NTRK, ALK, ROS1 and MET fusions have been classified in WHO CNS 5 under the umbrella term infant-type hemispheric gliomas due to their hemispheric predominance (96.7% of fusions) (247). Here, MET is linked to central nervous system cancer.